arginine vasopressin has been researched along with cardiovascular agents in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boes, A; Grond, J; Rodemann, HP; Wolthuis, A | 1 |
| Bemana, I; Kagawa, M; Nagao, S | 1 |
| Krum, H; Liew, D | 1 |
| EMBREY, MP | 1 |
| KARP, D; RINZLER, SH; TRAVELL, J | 1 |
| CLITHEROE, HJ; PICKLES, VR | 1 |
| Francis, GS; Tang, WH | 1 |
| Koch, T; Wenzel, V | 1 |
| Schweiger, TA; Zdanowicz, MM | 1 |
| Chen, H; Mastropietro, CW; Miletic, K; Rossi, NF | 1 |
| Fan, G; Han, J; Orgah, J; Wang, X; Yang, M; Zhang, B; Zhu, J; Zhu, Y | 1 |
2 review(s) available for arginine vasopressin and cardiovascular agents
| Article | Year |
|---|---|
New developments in the pharmacological treatment of chronic heart failure.
Topics: Arginine Vasopressin; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Erythropoietin; Glycation End Products, Advanced; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Matrix Metalloproteinase Inhibitors; Mineralocorticoid Receptor Antagonists | 2003 |
Vasopressin-receptor antagonists in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan | 2008 |
9 other study(ies) available for arginine vasopressin and cardiovascular agents
| Article | Year |
|---|---|
Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Cardiovascular Agents; Cell Division; Cells, Cultured; Fibronectins; Glomerular Mesangium; Protein Biosynthesis; Rats; Serotonin | 1992 |
Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Body Water; Brain Chemistry; Brain Edema; Cardiovascular Agents; Cerebrovascular Disorders; Cold Temperature; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley | 1996 |
A criterion of oxytocic activity.
Topics: Arginine Vasopressin; Cardiovascular Agents; Ergot Alkaloids; Female; Humans; Oxytocics; Uterus; Vasopressins | 1959 |
Effects of ergometrine (ergonovine) on the isolated atherosclerotic heart of the cholsterol-fed rabbit.
Topics: Angina Pectoris; Animals; Arginine Vasopressin; Cardiovascular Agents; Cholesterol, Dietary; Ergonovine; Ergot Alkaloids; Heart; Humans; Male; Oxytocics; Perfusion; Rabbits; Vasopressins | 1960 |
The effects of ambucetamide on human myometrial and other preparations, and its antagonism to the menstrual stimulant.
Topics: Acetamides; Animals; Arginine Vasopressin; Cardiovascular Agents; Cats; Central Nervous System Agents; Central Nervous System Stimulants; Dysmenorrhea; Felis; Female; Guinea Pigs; Humans; Menstruation; Muscle Relaxants, Central; Myometrium; Parasympatholytics; Rats; Uterus | 1960 |
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cardiovascular Agents; Heart Failure; Humans; Tolvaptan | 2004 |
[Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made].
Topics: Arginine Vasopressin; Cardiovascular Agents; Critical Care; Drug Approval; Drug Combinations; Drug Industry; Germany; Humans; Theophylline; Vasoconstrictor Agents | 2006 |
Effect of corticosteroids on arginine vasopressin after pediatric cardiac surgery.
Topics: Adrenal Cortex Hormones; Arginine Vasopressin; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiovascular Agents; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypotension; Infant; Male; Methylprednisolone; Prospective Studies; Regression Analysis; Vasoconstrictor Agents | 2014 |
Danhong injection attenuates cardiac injury induced by ischemic and reperfused neuronal cells through regulating arginine vasopressin expression and secretion.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cardiovascular Agents; Cell Hypoxia; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Glucose; Mitochondria; Myocytes, Cardiac; Neurons; Neuroprotective Agents; Rats, Wistar; Receptors, Vasopressin | 2016 |